NEW labeling on the cardiovascular effects related to Avandia and other diabetes meds

December 2007

You'll hear about NEW labeling on the cardiovascular effects related to Avandia and other diabetes meds.

This information on safety AND efficacy will be subject to misinterpretations...some intentional and some innocent.

Efficacy. The FDA will require label changes on ALL oral diabetes meds...saying that NONE of them are proven to REDUCE cardiovascular risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote